Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Study Population
- Inclusion criteria: People over 18 years old, who had got their tattoo more than one month ago (in the case of permanent tattoos), without a skin reaction during the evaluation and who signed the informed consent form.
- Exclusion criteria: People who did not sign the informed consent form or who presented a skin disorder associated with the tattoo, or any cutaneous active (with an outbreak in the previous five years) inflammatory disease (psoriasis, atopic dermatitis).
2.3. Study Variables Measurement
2.4. Statistical Analysis
3. Results
3.1. Participants’ Features
3.2. Skin Homeostasis Analysis between Skin with Permanent Tattoos and Non-Tattooed Skin
3.3. Skin Homeostasis Analysis between Skin with Adhesive Tattoos and Non-Tattooed Skin
3.4. Skin Homeostasis Analysis between Skin with Permanent Tattoos and Skin with Adhesive Tattoos
3.5. Skin Homeostasis Analysis Comparing before and after Petrolatum Application
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wohlrab, S.; Stahl, J.; Kappeler, P.M. Modifying the body: Motivations for getting tattooed and pierced. Body Image 2007, 4, 87–95. [Google Scholar] [CrossRef]
- Kluger, N.; Seité, S.; Taieb, C. The prevalence of tattooing and motivations in five major countries over the world. J. Eur. Acad. Dermatol. Venereol. 2019, 33, e484–e486. [Google Scholar] [CrossRef] [PubMed]
- Borkenhagen, A.; Mirastschijski, U.; Petrowski, K.; Brähler, E. Tattoos in Germany: Prevalence, demographics, and health orientation. Bundesgesundheitsblatt Gesundh. Gesundh. 2019, 62, 1077–1082. [Google Scholar] [CrossRef]
- Kluger, N.; Misery, L.; Seité, S.; Taieb, C. Tattooing: A national survey in the general population of France. J. Am. Acad. Dermatol. 2019, 81, 607–610. [Google Scholar] [CrossRef] [Green Version]
- Kluger, N. Epidemiology of tattoos in industrialized countries. Tattooed Skin Health 2015, 48, 6–20. [Google Scholar]
- Luetkemeier, M.J.; Hanisko, J.M.; Aho, K.M. Skin Tattoos Alter Sweat Rate and Na+ Concentration. Med. Sci. Sports Exerc. 2017, 49, 1432–1436. [Google Scholar] [CrossRef]
- Laux, P.; Tralau, T.; Tentschert, J.; Blume, A.; Al Dahouk, S.; Bäumler, W.; Bernstein, E.; Bocca, B.; Alimonti, A.; Colebrook, H.; et al. A medical-toxicological view of tattooing. Lancet 2016, 387, 395–402. [Google Scholar] [CrossRef]
- Sperry, K. Part I: History and methodology. Tattoos and tattooing. Am. J. Forensic. Med. Pathol. 1991, 12, 313–319. [Google Scholar] [CrossRef]
- Sperry, K. Tattoos and tattooing. Part II: Gross pathology, histopathology, medical complications, and applications. Am. J. Forensic. Med. Pathol. 1992, 13, 7–17. [Google Scholar] [CrossRef]
- Blasco-Morente, G.; Pérez-López, I.; Martínez-López, A.; Aneiros-Fernández, J.; Tercedor-Sánchez, J.; Arias-Santiago, S. Pigmented lymph nodes in a patient with melanoma: Tattoos. J. Eur. Acad. Dermatol. Venereol. 2015, 30, e116–e117. [Google Scholar] [CrossRef] [PubMed]
- Sepehri, M.; Sejersen, T.; Qvortrup, K.; Lerche, C.M.; Serup, J. Tattoo Pigments Are Observed in the Kupffer Cells of the Liver Indicating Blood-Borne Distribution of Tattoo Ink. Dermatology 2017, 233, 86–93. [Google Scholar] [CrossRef] [Green Version]
- Kazandjieva, J.; Tsankov, N. Tattoos: Dermatological complications. Clin. Dermatol. 2007, 25, 375–382. [Google Scholar] [CrossRef]
- Kluger, N.; Koljonen, V. Tattoos, inks, and cancer. Lancet Oncol. 2012, 13, e161–e168. [Google Scholar] [CrossRef]
- Navrazhina, K.; Goldman, B.; Leger, M.C. Atypical Intraepidermal Melanocytic Proliferation Masked by a Tattoo: Implications for Tattoo Artists and Public Health Campaigns. Cureus 2018, 10, e2975. [Google Scholar] [CrossRef] [Green Version]
- Morse, D.; Campana, J.; Biggar, R.J.; Haughie, G.E.V.B.J. Letter: Reactions to adhesive tattoos in children. N. Engl. J. Med. 1975, 293, 153. [Google Scholar]
- Rubio, L.; Guerra, E.; Garcia-Jares, C.; Lores, M. Body-decorating products: Ingredients of permanent and temporary tattoos from analytical and european regulatory perspectives. Anal. Chim. Acta 2019, 1079, 59–72. [Google Scholar] [CrossRef]
- Nørreslet, L.B.; Serup, J.; Kezic, S.; Engebretsen, K.A.; Thyssen, J.P.; Agner, T.; Clausen, M.-L. Tattoos and skin barrier function: Measurements of TEWL, stratum corneum conductance and capacitance, pH, and filaggrin. Ski. Res. Technol. 2019, 25, 382–388. [Google Scholar] [CrossRef]
- e-BQC | New Device for Antioxidant Capacity Determination [Internet]. Available online: http://e-bqc.com/ (accessed on 15 April 2020).
- Suetake, T.; Sasai, S.; Zhen, Y.X.; Ohi, T.; Tagami, H. Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. Arch. Dermatol. 1996, 132, 1453–1458. [Google Scholar] [CrossRef]
- Waring, M.; Bielfeldt, S.; Mätzold, K.; Wilhelm, K.; Butcher, M. An evaluation of the skin stripping of wound dressing adhesives. J. Wound Care 2011, 20, 412–422. [Google Scholar] [CrossRef] [PubMed]
- Montero-Vilchez, T.; Segura-Fernández-Nogueras, M.-V.; Pérez-Rodríguez, I.; Soler-Gongora, M.; Martinez-Lopez, A.; Fernández-González, A.; Molina-Leyva, A.; Arias-Santiago, S. Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity. J. Clin. Med. 2021, 10, 359. [Google Scholar] [CrossRef]
- Horimukai, K.; Morita, K.; Narita, M.; Kondo, M.; Kabashima, S.; Inoue, E.; Sasaki, T.; Niizeki, H.; Saito, H.; Matsumoto, K.; et al. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol. Int. 2016, 65, 103–108. [Google Scholar] [CrossRef] [Green Version]
- Montero-Vilchez, T.; Soler-Góngora, M.; Martínez-López, A.; Fernández-González, A.; Buendía-Eisman, A.; Molina-Leyva, A.; Arias-Santiago, S. Epidermal barrier changes in patients with psoriasis: The role of phototherapy. Photodermatol. Photoimmunol. Photomed. 2020. online ahead of print. [Google Scholar] [CrossRef]
- Alberto, J.; Leal, C.; Fernandes, C.; Lopes, P.A.; Paisana, H.; De Almeida, A.T.; Tavakoli, M. Fully Untethered Battery-free Biomonitoring Electronic Tattoo with Wireless Energy Harvesting. Sci. Rep. 2020, 10, 1–11. [Google Scholar] [CrossRef]
- Kubrak, O.I.; Atamaniuk, T.M.; Husak, V.V.; Drohomyretska, I.Z.; Storey, J.M.; Storey, K.B.; Lushchak, V.I. Oxidative stress responses in blood and gills of Carassius auratus exposed to the mancozeb-containing carbamate fungicide Tattoo. Ecotoxicol. Environ. Saf. 2012, 85, 37–43. [Google Scholar] [CrossRef] [PubMed]
- Furue, M. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Int. J. Mol. Sci. 2020, 21, 5382. [Google Scholar] [CrossRef] [PubMed]
- Draelos, Z.D. The science behind skin care: Moisturizers. J. Cosmet. Dermatol. 2018, 17, 138–144. [Google Scholar] [CrossRef]
- Samadi, A.; Nasrollahi, S.A.; Ashtiani, M.M.; Abels, C.; Firooz, A. Changes in skin barrier function following single and repeated applications of 4 types of moisturizers: A randomized controlled trial. J. Eur. Acad. Dermatol. Venereol. 2020, 34. [Google Scholar] [CrossRef] [PubMed]
- Elias, P.M.; Wakefield, J.S.; Man, M.-Q. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis. Skin Pharmacol. Physiol. 2019, 32, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Maarouf, M.; Kromenacker, B.W.; Brucks, E.S.; Hendricks, A.; Shi, V.Y. Reducing unpleasant side effects of topical 5-Fluorouracil treatment for actinic keratosis: A randomized controlled trial. J. Dermatol. Treat. 2019, 31, 175–179. [Google Scholar] [CrossRef]
- Schleider, N.R.; Moskowitz, R.S.; Cort, D.H.; Horwitz, S.N.; Frost, P. Effects of emollients on ultraviolet-radiation-induced erythema of the skin. Arch. Dermatol. 1979, 115, 1188–1191. [Google Scholar] [CrossRef] [PubMed]
- Soltanipoor, M.; Stilla, T.; Riethmüller, C.; Thyssen, J.P.; Sluiter, J.K.; Rustemeyer, T.; Fischer, T.W.; Kezic, S.; Angelova-Fischer, I. Specific barrier response profiles after experimentally induced skin irritation in vivo. Contact Dermat. 2018, 79, 59–66. [Google Scholar] [CrossRef]
- de Groot, A.C. Side-effects of henna and semi-permanent ‘black henna’ tattoos: A full review. Contact Dermat. 2013, 69, 1–25. [Google Scholar] [CrossRef]
- Bircher, A.J.; Hofmeier, K.S.; Schlegel, U.; Hauri, U. Genipin in Temporary Jagua Tattoos—Black Dye Causing Severe Allergic Dermatitis. Dermatitis 2019, 30, 375–376. [Google Scholar] [CrossRef]
Sociodemographic Features | Permanent Tattoos (n = 34) | Adhesive Tattoos (n = 33) |
---|---|---|
Age (years) (mean (range)) | 26.12 (21–41) | 26.45 (19–53) |
Gender, n (%) | ||
Male | 18 (52.9%) | 18 (54.5%) |
Female | 16 (47.1%) | 15 (45.5%) |
Phototype, n (%) | ||
I | 1 (2.9%) | 0 (0%) |
II | 4 (11.8%) | 4 (12.1%) |
III | 23 (67.6%) | 25 (75.8%) |
IV | 6 (17.6%) | 4 (12.1%) |
History of cutaneous pathology, n (%) | ||
Neoplasm | 2 (5.9%) | 0 (0%) |
Atopic dermatitis | 6 (17.6%) | 6 (18.2%) |
Other dermatitis | 2 (5.9%) | 0 (0%) |
Systemic medication, n (%) | ||
Contraceptives | 9 (26.5%) | 8 (24.2%) |
Other | 3 (8.8%) | 3 (9.1%) |
Topic medication, n (%) | ||
Corticoids | 5 (14.7%) | 2 (6.1%) |
Other | 0 (0%) | 2 (6.1%) |
Smokers | ||
n (%) | 9 (26.5%) | 2 (6.1%) |
Mean smoking pack per day (range) | 1.31 (0–25) | 0.24 (0–4) |
Drinkers, n (%) | ||
n (%) | 19 (55.9%) | 18 (54.5%) |
Mean alcohol unit/day (range) | 0.27 (0–1.14) | 0.25 (0–1) |
Tattoo duration (months) (mean (range)) | 24.62 (1–108) | - |
Pathologic reaction, n (%) | ||
Cutaneous allergy | 1 (2.9%) | 0 (0%) |
Itchiness | 2 (5.9%) | 0 (0%) |
Regular moisturizing, n (%) | 8 (23.5%) | 0 (0%) |
Localization, n (%) | ||
Head and neck | 3 (8.8%) | 0 (0%) |
Upper limbs | 19 (55.9%) | 33 (100%) |
Trunk | 8 (23.5%) | 0 (0%) |
Lower limbs | 4 (11.8%) | 0 (0%) |
Color, n (%) | ||
Black pigments only | 28 (82.4%) | 0 (0%) |
Other combinations | 6 (17.6%) | 33 (100%) |
Before Moisturizer (n = 34) | After Moisturizer (n = 34) | |||||
---|---|---|---|---|---|---|
Skin with Permanent Tattoos | Non-Tattooed Skin | p | Skin with Permanent Tattoos | Non-Tattooed Skin | p | |
Temperature (°C) | 30.47 (1.46 SD) | 31.01 (1.27 SD) | 0.001 * | 30.18 (1.37 SD) | 30.61 (1.32 SD) | <0.001 ** |
TEWL (g/h/m2) | 8.72 (5.42 SD) | 8.36 (5.80 SD) | 0.857 | 7.90 (4.03 SD) | 8.84 (5.67 SD) | 0.433 |
SCH (AU) | 48.24 (16.95 SD) | 44.15 (15.26 SD) | 0.008 * | 44.32 (13.05 SD) | 40.78 (13.17 SD) | 0.047 ** |
Erythema (AU) | 96.77 (141.43 SD) | 280.08 (88.76 SD) | <0.001 * | 98.33 (142.78 SD) | 258.00 (94.46 SD) | <0.001 ** |
Q1 (uC) | 0.97 (0.46 SD) | 1.08 (0.64 SD) | 0.490 | - | - | - |
Q2 (uC) | 4.44 (1.36 SD) | 4.13 (1.21 SD) | 0.235 | - | - | - |
QT (uC) | 5.40 (1.71 SD) | 5.20 (1.50 SD) | 0.598 | - | - | - |
Before Moisturizer (n = 33) | After Moisturizer (n = 33) | |||||
---|---|---|---|---|---|---|
Skin with Adhesive Tattoos | Non-Tattooed Skin | p | Skin with Adhesive Tattoos | Non-Tattooed Skin | p | |
Temperature (°C) | 30.78 (1.11 SD) | 32.05 (0.86 SD) | <0.001 * | 31.83 (0.68 SD) | 32.32 (0.66 SD) | <0.001 ** |
TEWL (g/h/m2) | 8.65 (3.11 SD) | 6.99 (2.10 SD) | 0.003 * | 7.31 (2.14 SD) | 7.88 (1.63 SD) | 0.062 |
SCH (AU) | 21.19 (6.71 SD) | 41.31 (9.18 SD) | <0.001 * | 16.37 (7.27 SD) | 31.45 (9.99 SD) | <0.001 ** |
Erythema (AU) | 312.20 (211.14 SD) | 212.61 (37.01 SD) | 0.021 * | 335.34 (225.93 SD) | 194.67 (38.88 SD) | 0.001 ** |
Q1 (uC) | 0.17 (0.17 SD) | 0.62 (0.38 SD) | <0.001 * | - | - | - |
Q2 (uC) | 1.10 (0.76 SD) | 2.86 (1.18 SD) | <0.001 * | - | - | - |
QT (uC) | 1.27 (0.91 SD) | 3.48 (1.51 SD) | <0.001 * | - | - | - |
Before Moisturizer | After Moisturizer | |||||
---|---|---|---|---|---|---|
Skin with Permanent Tattoos (n = 34) | Skin with Adhesive Tattoos (n = 33) | p | Skin with Permanent Tattoos (n = 34) | Skin with Adhesive Tattoos (n = 33) | p | |
Temperature (°C) | 30.47 (1.46 SD) | 30.78 (1.11 SD) | 0.322 | 30.18 (1.37 SD) | 31.83 (0.68 SD) | <0.001 ** |
TEWL (g/h/m2) | 8.72 (5.42 SD) | 8.65 (3.11 SD) | 0.132 | 7.90 (4.03 SD) | 7.31 (2.14 SD) | 0.888 |
SCH (AU) | 48.24 (16.95 SD) | 21.19 (6.71 SD) | <0.001 * | 44.32 (13.05 SD) | 16.37 (7.27 SD) | <0.001 ** |
Erythema (AU) | 96.77 (141.43 SD) | 312.20 (211.14 SD) | <0.001 * | 98.33 (142.78 SD) | 335.34 (225.93 SD) | <0.001 ** |
Q1 (uC) | 0.97 (0.46 SD) | 0.17 (0.17 SD) | <0.001 * | - | - | - |
Q2 (uC) | 4.44 (1.36 SD) | 1.10 (0.76 SD) | <0.001 * | - | - | - |
QT (uC) | 5.40 (1.71 SD) | 1.27 (0.91 SD) | <0.001 * | - | - | - |
Non-Tattooed Skin (n = 34) | Skin with Permanent Tattoos (n = 34) | Skin with Adhesive Tattoos (n = 33) | |||||||
---|---|---|---|---|---|---|---|---|---|
After Moisturization | Mean Difference between before and after Moisturization | p Value Comparing before vs. after Moisturization | After Moisturization | Mean Difference between before and after Moisturization | p Value Comparing before vs. after Moisturization | After Moisturization | Mean Difference between before and after Moisturization | p Value Comparing before vs. after Moisturization | |
Temperature (°C) | 30.61 (1.32 SD) | −0.36 (0.73 SD) | 0.008 * | 30.18 (1.37 SD) | −0.26 (0.74 SD) | 0.050 ** | 31.83 (0.68 SD) | +1.05 (0.89 SD) | <0.001 *** |
TEWL (g/h/m2) | 8.84 (5.67 SD) | +0.33 (6.88 SD) | 0.268 | 7.90 (4.03 SD) | −0.83 (6.32 SD) | 0.903 | 7.31 (2.14 SD) | −1.35 (3.28 SD) | 0.025 *** |
SCH (AU) | 40.78 (13.17 SD) | −4.01 (17.49 SD) | 0.197 | 44.32 (13.05 SD) | −4.26 (18.15 SD) | 0.187 | 16.37 (7.27 SD) | −4.83 (5.00 SD) | <0.001 *** |
Erythema (AU) | 258.85 (94.46 SD) | −21.56 (30.16 SD) | <0.001 * | 98.33 (142.78 SD) | +2.29 (24.76 SD) | 0.875 | 335.34 (225.93 SD) | +23.14 (143.93 SD) | 0.396 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Serrano-Serra, J.-P.; Montero-Vilchez, T.; Buendia-Eisman, A.; Arias-Santiago, S. Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study. J. Clin. Med. 2021, 10, 888. https://doi.org/10.3390/jcm10040888
Serrano-Serra J-P, Montero-Vilchez T, Buendia-Eisman A, Arias-Santiago S. Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study. Journal of Clinical Medicine. 2021; 10(4):888. https://doi.org/10.3390/jcm10040888
Chicago/Turabian StyleSerrano-Serra, Jose-Pablo, Trinidad Montero-Vilchez, Agustin Buendia-Eisman, and Salvador Arias-Santiago. 2021. "Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study" Journal of Clinical Medicine 10, no. 4: 888. https://doi.org/10.3390/jcm10040888
APA StyleSerrano-Serra, J. -P., Montero-Vilchez, T., Buendia-Eisman, A., & Arias-Santiago, S. (2021). Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study. Journal of Clinical Medicine, 10(4), 888. https://doi.org/10.3390/jcm10040888